LISA KIM: Open Payments
NPI 1588373120 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,099 in 55 payments from 12 companies in 2025. Trend: 2023 $182 · 2024 $789 · 2025 $2,099
Food & beverage: $2,099
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $462 |
| Madrigal Pharmaceuticals | 8 | $461 |
| Janssen Biotech, Inc. | 11 | $326 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $208 |
| Mallinckrodt Hospital Products Inc. | 1 | $146 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Ipsen Biopharmaceuticals, Inc | 4 | $111 |
| Celltrion USA Inc. | 4 | $97 |
| PFIZER INC. | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
Products named: REZDIFFRA, TREMFYA, SKYRIZI, ENTYVIO, RINVOQ, TERLIVAZ, ZENPEP, IQIRVO.
Industry payments across HI — which companies pay providers there.
